COFCO Biotechnology Co., Ltd. (SHE:000930)
China · Delayed Price · Currency is CNY 5.26
-0.16 (-2.95%)
Sep 24, 2026, 3:04 PM CST
COFCO Biotechnology Revenue
COFCO Biotechnology had revenue of 4.32B CNY in the quarter ending June 30, 2026, a decrease of -2.52%. This brings the company's revenue in the last twelve months to 16.89B, down -10.87% year-over-year. In the year 2025, COFCO Biotechnology had annual revenue of 17.51B, down -12.67%.
Revenue (ttm)
16.89B
Revenue Growth
-10.87%
P/S Ratio
0.58
Revenue / Employee
3.70M
Employees
4,571
Market Cap
9.76B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.51B | -2.54B | -12.67% |
| Dec 31, 2024 | 20.05B | -325.59M | -1.60% |
| Dec 31, 2023 | 20.38B | 460.90M | 2.31% |
| Jan 1, 2023 | 19.92B | -3.64B | -15.46% |
| Jan 1, 2022 | 23.56B | 3.65B | 18.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.